(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide

C108H130N16O17S2 — CID 157432512

IUPAC(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
SMILESCC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(C2=CCCC2)cc1)N1Cc2ccccc2C1=O.CC[C@H](NC(C)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1.COC1=CC(=O)N([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)C)C1.Cc1c(-c2ccc(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3Cc4ccccc4C3=O)cc2)ncn1C
InChIInChI=1S/C30H35N5O4.C30H35N3O4.C26H32N4O5S.C22H28N4O4S/c1-18(2)27(35-15-22-7-5-6-8-24(22)29(35)38)30(39)34-16-23(36)13-25(34)28(37)31-14-20-9-11-21(12-10-20)26-19(3)33(4)17-32-26;1-19(2)27(33-17-23-9-5-6-10-25(23)29(33)36)30(37)32-18-24(34)15-26(32)28(35)31-16-20-11-13-22(14-12-20)21-7-3-4-8-21;1-15(2)23(30-13-20(35-4)10-22(30)32)26(34)29-12-19(31)9-21(29)25(33)27-11-17-5-7-18(8-6-17)24-16(3)28-14-36-24;1-4-18(25-14(3)27)22(30)26-11-17(28)9-19(26)21(29)23-10-15-5-7-16(8-6-15)20-13(2)24-12-31-20/h5-12,17-18,23,25,27,36H,13-16H2,1-4H3,(H,31,37);5-7,9-14,19,24,26-27,34H,3-4,8,15-18H2,1-2H3,(H,31,35);5-8,10,14-15,19,21,23,31H,9,11-13H2,1-4H3,(H,27,33);5-8,12,17-19,28H,4,9-11H2,1-3H3,(H,23,29)(H,25,27)/t23-,25+,27+;24-,26+,27+;19-,21+,23+;17-,18+,19+/m1111/s1
InChIKeyBQSABXSOFDLNQG-NWAFRIABSA-N
MW1988.46 g/mol
LogP9.87
Rot. Bonds29

About (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide

(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide (PubChem CID 157432512) has the molecular formula C108H130N16O17S2 and a molecular weight of 1988.46 g/mol. Its IUPAC name is (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
PubChem CID157432512
Molecular FormulaC108H130N16O17S2
Molecular Weight1988.46 g/mol
Exact Mass1986.92
IUPAC Name(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
SMILESCC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(C2=CCCC2)cc1)N1Cc2ccccc2C1=O.CC[C@H](NC(C)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1.COC1=CC(=O)N([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)C)C1.Cc1c(-c2ccc(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3Cc4ccccc4C3=O)cc2)ncn1C
InChIInChI=1S/C30H35N5O4.C30H35N3O4.C26H32N4O5S.C22H28N4O4S/c1-18(2)27(35-15-22-7-5-6-8-24(22)29(35)38)30(39)34-16-23(36)13-25(34)28(37)31-14-20-9-11-21(12-10-20)26-19(3)33(4)17-32-26;1-19(2)27(33-17-23-9-5-6-10-25(23)29(33)36)30(37)32-18-24(34)15-26(32)28(35)31-16-20-11-13-22(14-12-20)21-7-3-4-8-21;1-15(2)23(30-13-20(35-4)10-22(30)32)26(34)29-12-19(31)9-21(29)25(33)27-11-17-5-7-18(8-6-17)24-16(3)28-14-36-24;1-4-18(25-14(3)27)22(30)26-11-17(28)9-19(26)21(29)23-10-15-5-7-16(8-6-15)20-13(2)24-12-31-20/h5-12,17-18,23,25,27,36H,13-16H2,1-4H3,(H,31,37);5-7,9-14,19,24,26-27,34H,3-4,8,15-18H2,1-2H3,(H,31,35);5-8,10,14-15,19,21,23,31H,9,11-13H2,1-4H3,(H,27,33);5-8,12,17-19,28H,4,9-11H2,1-3H3,(H,23,29)(H,25,27)/t23-,25+,27+;24-,26+,27+;19-,21+,23+;17-,18+,19+/m1111/s1
InChIKeyBQSABXSOFDLNQG-NWAFRIABSA-N
XLogP9.87
TPSA421.42 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds29
Heavy Atoms143
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001988.46
LogP ≤ 59.87
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Analyze (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide?
The IUPAC name of (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide (CID 157432512) is (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide is CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(C2=CCCC2)cc1)N1Cc2ccccc2C1=O.CC[C@H](NC(C)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1.COC1=CC(=O)N([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)C)C1.Cc1c(-c2ccc(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3Cc4ccccc4C3=O)cc2)ncn1C.
What is the InChIKey of (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide?
The InChIKey is BQSABXSOFDLNQG-NWAFRIABSA-N. The full InChI is InChI=1S/C30H35N5O4.C30H35N3O4.C26H32N4O5S.C22H28N4O4S/c1-18(2)27(35-15-22-7-5-6-8-24(22)29(35)38)30(39)34-16-23(36)13-25(34)28(37)31-14-20-9-11-21(12-10-20)26-19(3)33(4)17-32-26;1-19(2)27(33-17-23-9-5-6-10-25(23)29(33)36)30(37)32-18-24(34)15-26(32)28(35)31-16-20-11-13-22(14-12-20)21-7-3-4-8-21;1-15(2)23(30-13-20(35-4)10-22(30)32)26(34)29-12-19(31)9-21(29)25(33)27-11-17-5-7-18(8-6-17)24-16(3)28-14-36-24;1-4-18(25-14(3)27)22(30)26-11-17(28)9-19(26)21(29)23-10-15-5-7-16(8-6-15)20-13(2)24-12-31-20/h5-12,17-18,23,25,27,36H,13-16H2,1-4H3,(H,31,37);5-7,9-14,19,24,26-27,34H,3-4,8,15-18H2,1-2H3,(H,31,35);5-8,10,14-15,19,21,23,31H,9,11-13H2,1-4H3,(H,27,33);5-8,12,17-19,28H,4,9-11H2,1-3H3,(H,23,29)(H,25,27)/t23-,25+,27+;24-,26+,27+;19-,21+,23+;17-,18+,19+/m1111/s1.
What are the key properties of (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide?
(2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide has a molecular weight of 1988.46 g/mol, XLogP of 9.87, 29 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4R)-1-[(2S)-2-acetamidobutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(cyclopenten-1-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-N-[[4-(1,5-dimethylimidazol-4-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;(2S,4R)-4-hydroxy-1-[(2S)-2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-3-methylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide is sourced from PubChem (CID 157432512), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).